Business Context and Reporting Period
Company: Immersion Corporation (IMMR)
Filing Type: Form 8-K (Current Report)
Date of Report: November 7, 2025
Event: Adoption of a Rights Agreement (Poison Pill) to protect stockholders from coercive or unfair takeover tactics.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance and capital structure changes.
- Outstanding Common Shares (as of Nov 7, 2025): 50,029,484
- Dividend Declared: One preferred share purchase Right for each Common Share.
- Right Exercise Price: $20.58 per one one-thousandth of a Preferred Share.
- Redemption Price: $0.001 per Right (subject to Board discretion prior to Distribution Date).
Material Changes
The Board of Directors declared a dividend of Rights to holders of record as of November 17, 2025. This action modifies the rights of security holders by introducing a mechanism that imposes significant dilution penalties on any person or group acquiring 9.99% or more of the Common Stock without Board approval.
- Trigger Threshold: 9.99% beneficial ownership by an "Acquiring Person."
- Flip-In Event: Upon triggering, Rights holders may purchase Common Shares at 50% of the current market price, causing substantial dilution to the acquirer.
- Flip-Over Event: In the event of a merger or asset sale, Rights convert into shares of the acquiring entity at a discounted price.
- Expiration: Rights expire on October 31, 2026, unless extended by the Board and ratified by stockholders.
Guidance, Outlook, and Risks
Management Commentary: The Rights Agreement was not adopted in response to any specific takeover bid. It is intended to discourage unsolicited business combinations while not interfering with Board-approved transactions.
Risks and Contingencies:
- Anti-Takeover Effect: The Rights may render a merger or tender offer more difficult or discourage such offers entirely if not approved by the Board.
- Dilution Risk: Substantial dilution will occur for any acquirer crossing the 9.99% threshold without Board consent.
- Redemption: The Board retains the sole discretion to redeem all Rights at $0.001 per Right at any time before the Distribution Date.
Investor Verification Checklist
- Verify the Record Date of November 17, 2025, to confirm eligibility for the Rights dividend.
- Review the full Rights Agreement (Exhibit 4.1) for specific definitions of "Acquiring Person" and "Exempt Persons."
- Monitor for any future Board announcements regarding the redemption of Rights or extension of the expiration date beyond October 31, 2026.
- Check for any subsequent filings indicating a specific takeover bid that may have triggered the Rights mechanism.